Allergan PLC (AGN)

247.35
NYSE : Health Care
Prev Close 246.93
Day Low/High 245.67 / 248.29
52 Wk Low/High 184.50 / 301.32
Avg Volume 4.30M
Exchange NYSE
Shares Outstanding 374.95M
Market Cap 92.59B
EPS 38.20
P/E Ratio N/A
Div & Yield 2.80 (1.10%)

Latest News

Deals of the Week: Valentine Couplings and Breakups

Deals of the Week: Valentine Couplings and Breakups

SoftBank's $3.3 billion deal for Fortress topped the notable transactions this week.

5 Ways Allergan Can Keep Up Momentum

5 Ways Allergan Can Keep Up Momentum

Allergan's most-recent quarterly financial report for Q4/2016 showed solid results.

Biotech Buoyed by Deal Talk

Biotech Buoyed by Deal Talk

M&A activity is in a serious upswing, and here are some names to watch.

Wall Street Smashes Records for Fourth Day in a Row After Rocky Session

Wall Street Smashes Records for Fourth Day in a Row After Rocky Session

Wall Street smashes records again on Tuesday, closing at all-time highs for its fourth consecutive session.

Stocks Find Upward Momentum Again as Chances of a Rate Hike Rise

Stocks Find Upward Momentum Again as Chances of a Rate Hike Rise

Wall Street hold small gains on Tuesday after Federal Reserve Chair Janet Yellen plays the part of both dove and hawk.

Stocks Mixed as Fed's Yellen Talks Rates on Capitol Hill

Stocks Mixed as Fed's Yellen Talks Rates on Capitol Hill

Wall Street is mixed on Tuesday morning after Federal Reserve Chair Janet Yellen champions the strength of the U.S. economy.

Valeant, Pershing Square to Split Legal Fees on Allergan Lawsuit

Valeant, Pershing Square to Split Legal Fees on Allergan Lawsuit

The two will split litigation fees 50-50.

New Relic: Cramer's Top Takeaways

New Relic: Cramer's Top Takeaways

CEO Lew Cirne tells Jim Cramer New Relic is using cloud analytics to help companies gain better insight.

VMware: Cramer's Top Takeaways

VMware: Cramer's Top Takeaways

VMware CEO Pat Gelsinger tells Jim Cramer that technology is now touching virtually every aspect of business.

Intel: Cramer's Top Takeaways

Intel: Cramer's Top Takeaways

CEO Bryan Krzanich tells Jim Cramer that Intel is always thinking five years into the future.

Chesapeake Energy, Priceline, Schlumberger, ZELTIQ : 'Mad Money' Lightning Round

Chesapeake Energy, Priceline, Schlumberger, ZELTIQ : 'Mad Money' Lightning Round

Jim Cramer's bullish on ZELTIQ Aesthetics, Chesapeake Energy, Priceline Group and more.

Why These Market Gains Are More Powerful Than Trump: Cramer's 'Mad Money' Recap (Monday 2/13/17)

Why These Market Gains Are More Powerful Than Trump: Cramer's 'Mad Money' Recap (Monday 2/13/17)

Jim Cramer says it's a sea change: It's not just about economic growth, it's about global growth without inflation.

Dow, S&P 500 and Nasdaq Score New Records for Third Straight Day

Dow, S&P 500 and Nasdaq Score New Records for Third Straight Day

The good vibes that carried Wall Street to new records last week lingered on into Monday's session.

Stocks Extend Gains, on Track to Close at Records for Third Day in Row

Stocks Extend Gains, on Track to Close at Records for Third Day in Row

The Dow Jones Industrial Average led Wall Street's gains on Monday on leftover goodwill from last week's Trump-inspired rally.

Allergan in Good Shape With Acquisition

Buying Zeltiq Aesthetics expands position in body contouring.

How to Trade Monday's Most Active Stocks: BofA, Vale, Zeltiq, Teva and More

How to Trade Monday's Most Active Stocks: BofA, Vale, Zeltiq, Teva and More

Here's how to trade seven of the most active names on the market.

Allergan Shares Surge After Announcing Acquisition of Zeltiq Aesthetics

Allergan Shares Surge After Announcing Acquisition of Zeltiq Aesthetics

Allergan shares are rising on news the company is purchasing medical tech company Zeltiq Aesthetics for roughly $2.5 billion.

Sears, Kmart Drop Trump Lines; Stocks Trade at Records: Midday Report

Sears, Kmart Drop Trump Lines; Stocks Trade at Records: Midday Report

Stocks trade above record highs set on Friday as good vibes over the potential Trump tax reform plan are sustained over the weekend.

Allergan Shares Rise on $2.5B Deal for Body-Sculptor Zeltiq

Allergan Shares Rise on $2.5B Deal for Body-Sculptor Zeltiq

Allergan is buying body-sculptor Zeltiq. CEO Brent Saunders deems it to be the Botox of 10 years ago and he expects the deal to be immediately accretive.

Stocks Trade Above Record Closes, Apple Nears All-Time High

Stocks Trade Above Record Closes, Apple Nears All-Time High

Stocks edge higher on Monday as good vibes from Friday's record-breaking rally are sustained through the weekend.

Stock Futures Take Baby Steps in Effort to Extend Friday's Record Run

Stock Futures Take Baby Steps in Effort to Extend Friday's Record Run

Stock futures edge higher on Monday morning as good vibes from Friday's record-breaking rally are sustained through the weekend.

Allergan To Acquire ZELTIQ, Best-in-Class Company In Fast-Growing Body Contouring Segment, For $2.47 Billion

Allergan To Acquire ZELTIQ, Best-in-Class Company In Fast-Growing Body Contouring Segment, For $2.47 Billion

- Immediately Accretive All Cash Transaction Expected to Close in the Second Half of 2017 -

Why Dump Good Stocks?; Gamers, Oil and Industrials Take a Ride: Jim Cramer's Best Blog

Why Dump Good Stocks?; Gamers, Oil and Industrials Take a Ride: Jim Cramer's Best Blog

Jim Cramer ponders what makes people dump good stocks and discusses the ride gamers, oil and industrials took.

Weekly Roundup

Earnings and talk of the administration's tax plan invigorate markets. We add 2 positions to the portfolio and drop an energy name.

Cramer: Why Are People Dumping Such Good Stocks?

Cramer: Why Are People Dumping Such Good Stocks?

Amazon, J&J, IBM and others don't deserve this treatment.

Bonds Call the Tune Today, Not Stocks: Cramer's 'Mad Money' Recap (Thursday 2/9/17)

Bonds Call the Tune Today, Not Stocks: Cramer's 'Mad Money' Recap (Thursday 2/9/17)

When bond yields rise, the economy roars and it's game on for industrials, banks and retailers, says Jim Cramer.

Cramer: Here's the Reason for Allergan's Remarkable Run

Cramer: Here's the Reason for Allergan's Remarkable Run

Static doesn't work in this industry. Pipelines work.